These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30010140)
1. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease. Liu H; Huang Y; Li J J Integr Neurosci; 2018; 17(3-4):619-631. PubMed ID: 30010140 [TBL] [Abstract][Full Text] [Related]
2. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease. Wang Y; Wang Z Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219 [TBL] [Abstract][Full Text] [Related]
3. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes. George G; Valiya Parambath S; Lokappa SB; Varkey J Gene; 2019 May; 697():67-77. PubMed ID: 30776463 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140 [TBL] [Abstract][Full Text] [Related]
5. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease. Li J; Sun Y; Chen J J Mol Neurosci; 2018 Aug; 65(4):527-535. PubMed ID: 30083784 [TBL] [Abstract][Full Text] [Related]
6. Analysis of key candidate genes and pathways of endometriosis pathophysiology by a genomics-bioinformatics approach. Zhang Z; Ruan L; Lu M; Yao X Gynecol Endocrinol; 2019 Jul; 35(7):576-581. PubMed ID: 30798642 [TBL] [Abstract][Full Text] [Related]
7. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease. Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570 [TBL] [Abstract][Full Text] [Related]
8. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis. Guo Y; Bao Y; Ma M; Yang W Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling predicts pathways and genes associated with Parkinson's disease. Liu S; Zhang Y; Bian H; Li X Neurol Sci; 2016 Jan; 37(1):73-79. PubMed ID: 26269422 [TBL] [Abstract][Full Text] [Related]
10. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566 [TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease. Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomic profiles in Parkinson's disease. Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011 [TBL] [Abstract][Full Text] [Related]
13. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra. Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. Ofori E; Pasternak O; Planetta PJ; Li H; Burciu RG; Snyder AF; Lai S; Okun MS; Vaillancourt DE Brain; 2015 Aug; 138(Pt 8):2322-31. PubMed ID: 25981960 [TBL] [Abstract][Full Text] [Related]
15. Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways. Ferraro F; Fevga C; Bonifati V; Mandemakers W; Mahfouz A; Reinders M Cells; 2022 Jan; 11(2):. PubMed ID: 35053314 [TBL] [Abstract][Full Text] [Related]
16. Flotillin-1 in the substantia nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain. Jacobowitz DM; Kallarakal AT Neurotox Res; 2004; 6(4):245-57. PubMed ID: 15545008 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. Hill WD; Arai M; Cohen JA; Trojanowski JQ J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]